Company Book It Local Inc OTC Bulletin Board

US0985431016

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2019	Biohemp International, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019	CI
2019	Biohemp International, Inc. Enters Agreement with American Premium Water Corporation to White Label Cannabidiol Infused Water Utilizing HIPH’s Proprietary Hydro Nano Technology	CI

BioHemp International, Inc., formerly Blake Insomnia Therapeutics, Inc., is a development-stage pharmaceutical company. The Company operates as a provider of insomnia remedy. The Company is focused on developing its business plan for an insomnia medication known as Zleepax. Zleepax is a sleep aid with beta-blockers as an active agent. As of August 31, 2016, the Company had no revenues.

Managers	Title	Age	Since
Daniel Blum CEO	Chief Executive Officer	35	19-05-14

Members of the board	Title	Age	Since
Daniel Blum CEO	Chief Executive Officer	35	19-05-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,487,063	14,517 ( 0.5837 %)	0	0.5837 %

Biohemp International, Inc.

244 5th Avenue Suite A-154

10001, New York

+646-453-4912

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals